BUY Ramkrishna Forgings Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: Swing (≤2wk)17 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·28 Aug · today
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·28 Aug · today
Chaitanya Jalan Steps Up as Joint Managing Director at Ramkrishna Forgings Limited
NewsGoogle News·25 Aug · 3d ago
Ramkrishna Forgings gets NOC to reclassify promoter entity as public
NewsGoogle News·6 Aug · 3w ago
Ramkrishna Forgings reports zero fatalities, 9.40% emission cut in FY26
NewsGoogle News·5 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ramkrishna Forgings
- BUY — Vinay Rajani, HDFC Securities7 Oct 2026 · ~2 weeks · target ₹775 · SL hit
- BUY — Rakesh Bansal6 Oct 2026 · ~2 weeks · target ₹785 · SL hit
- BUY — Sudeep Shah, SBICAP Securities6 Oct 2026 · ~3 months · target ₹810 · SL hit
- BUY — IDBI Capital6 Oct 2026 · ~3 months · target ₹803 · SL hit
- BUY — Jatin Gedia, TM Investment Technologies29 Sept 2026 · ~2 weeks · target ₹735 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

